Cabiralizumab (Anti-CSF1R / M-CSFR / CD115)
Cabiralizumab (Anti-CSF1R / M-CSFR / CD115) (A2644-GRP)
Products
Description
Cabiralizumab (Anti-CSF1R / M-CSFR / CD115) is an monoclonal antibody (MAb) targeting CSF1R. It can be used in the research of rheumatoid arthritis (RA), melanoma, kidney cancer, or non-small cell lung cancer. MW :146.3 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2644 |
| Target | CSF-1R |